InsidersTradesSigma
Follow the Kaleido Biosciences, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Kaleido Biosciences, Inc. has logged 2 public disclosures. Market capitalisation: €4k. The latest transaction was filed on 2 March 2022 (Retenue fiscale). Among the most active insiders: van Hylckama Vlieg Johan. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Kaleido Biosciences, Inc. is a company focused on developing microbiome-based therapies to treat various diseases. It emphasizes innovation in the healthcare and pharmaceutical sectors.